Comera Life Sciences Holdings- Warrants (19/05/2027) Net Income

Comera Life Sciences Holdings- Warrants (19/05/2027) (CMRAW) currently reports a net income of $-84M as of September 2023. That compares with $-23M in the prior-year period — down 264.0% year over year. That is below the sector sector average of $96M. Use the charts on this page to explore Comera Life Sciences Holdings- Warrants (19/05/2027)'s net income history and peer comparisons.

Comera Life Sciences Holdings- Warrants (19/05/2027)'s net income decreased from $-23M to $-84M — a 264.0% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Comera Life Sciences Holdings- Warrants (19/05/2027)'s net income of $-84M is lower than the its sector sector average of $96M. That is roughly 187.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Comera Life Sciences Holdings- Warrants (19/05/2027) reported $-84M in net income as of September 2023. That compares with $-23M in the prior-year period — down 264.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-84M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $96M. From there, open related valuation or income-statement pages for Comera Life Sciences Holdings- Warrants (19/05/2027), and consider following CMRAW for alerts when major investors trade the stock.